Related references
Note: Only part of the references are listed.Respiratory depression after neuraxial opioids in the obstetric setting
Brendan Carvalho
ANESTHESIA AND ANALGESIA (2008)
Differences in δ- and μ-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects
Elise M. Weerts et al.
NEUROPSYCHOPHARMACOLOGY (2008)
The latent phase of labor: Diagnosis and management
Betsy Greulich et al.
JOURNAL OF MIDWIFERY & WOMENS HEALTH (2007)
μ-opioid receptor preferentially inhibits oxytocin release from neurohypophysial terminals by blocking R-type Ca2+ channels
S Ortiz-Miranda et al.
JOURNAL OF NEUROENDOCRINOLOGY (2005)
Eliminating analgesic meperidine use with a supported formulary restriction
AB O'Connor et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Meperidine is alive and well in the new millennium: Evaluation of meperidine usage patterns and frequency of adverse drug reactions
CE Seifert et al.
PHARMACOTHERAPY (2004)
Mu opioid modulation of oxytocin secretion in late pregnant and parturient rats - Involvement of noradrenergic neurotransmission
S Kutlu et al.
NEUROENDOCRINOLOGY (2004)
μ-opioid receptor modulates peptide release from rat neurohypophysial terminals by inhibiting Ca2+ influx
SI Ortiz-Miranda et al.
JOURNAL OF NEUROENDOCRINOLOGY (2003)
Opioid modulation of magnocellular neurosecretory cell activity
CH Brown et al.
NEUROSCIENCE RESEARCH (2000)
The kappa opioid receptor and dynorphin co-localize in vasopressin magnocellular neurosecretory neurons in guinea-pig hypothalamus
SJ Shuster et al.
NEUROSCIENCE (2000)
Share Paper
